Articles By RheumNow
CRP in SSc: Identifying a Severe Phenotype
By RheumNow
Patients with systemic sclerosis (SSc) who have persistent inflammation -- characterized by consistently elevated levels of C-reactive protein (CRP) -- have more severe disease and worse outcomes, a retrospective study confirmed.
Read Article
Apremilast Reduces Oral Ulcers in Behcet's Syndrome
By RheumNow
A multinational trial finds a statistically significant number of patients with Behçet's syndrome showed a greater reduction in the number of oral ulcers with apremilast compared with placebo.
Read Article
In RA, Activity Protects Cognition
By RheumNow
Physical activity appeared to be protective against the development of cognitive impairments among patients with rheumatoid arthritis (RA), a prospective cohort study found.
Read Article
Year in Review - Psoriatic Arthritis 2019
By RheumNow
Major new insights into the treatment of psoriatic arthritis dominated the headlines during the past year, with a head-to-head trial comparing IL-17A inhibition with tumor necrosis factor blockade, another study considering whether methotrexate can improve outcomes with anti-TNF therapy in PsA, and an investigation into the effects of biologic therapy on bone.
Read Article
Psoriasis Risk Increased with TNF Inhibitors in Juveniles
By RheumNow
Children with inflammatory diseases who were treated with tumor necrosis factor (TNF) inhibitors had a higher rate of incident psoriasis than those not exposed to these biologics, a single-center retrospective study found.
Read Article
Comorbidities Increase in Importance in RA
By RheumNow
Patients with rheumatoid arthritis (RA) have a large comorbidity burden at the time of diagnosis, including a wide range of ailments but with pulmonary disease a particular concern, a U.K. population-based study found.
Read Article
Joint Injections: Are They Worth the Risk?
By RheumNow
Intra-articular injections of corticosteroids for relief of the pain of hip or knee osteoarthritis (OA) may have adverse long-term consequences, researchers suggested.
Read Article
Myositis Patients at High Risk of Opportunistic Infections
By RheumNow
Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found.
Read Article
NSAID Use Linked With Hypertension in Ankylosing Spondylitis
By RheumNow
Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) among patients with ankylosing spondylitis (AS) was associated with the development of incident hypertension, a prospective cohort study found.
Read Article
Anakinra Shows Benefits in Cytokine Storm
By RheumNow
The interleukin (IL)-1 receptor antagonist anakinra (Kineret) showed promise in critically ill children who develop the often-lethal condition known as secondary hemophagocytic lymphohistiocytosis (sHLH)/macrophage activation syndrome (MAS), a retrospective single-center study found.
Read Article